What is the primary application of this trocar?

It is applicable for tissue puncture in laparoscopic surgery.

Premium Atranmatic Trocar for Effective Minimally Invasive Surgery

Name: Premium Atranmatic Trocar for Effective Minimally Invasive Surgery
Brand: Changzhou Medical Bioengineering Co., Ltd.
SKU: 1921294345

Jiangsu, ChinaChangzhou Medical Bioengineering Co., Ltd.

US$10.00-12.00

100 Pieces

Sample price:US$10.00/piece.Request sample

Product profile

Customization

Available

Application

Abdominal, Microsurgery

Material

Plastic

Model NO.

CS-TC

Feature

Disposable

Certification

CE, ISO13485

Group

Adult

Diamater

5mm,10mm,12mm,15mm

Color

Transparent

Bladeless

Yes

Certificate

CE,ISO13485,Fsc

Transport Package

Corrugated Package

Trademark

CYS

Origin

China

HS Code

9018909919

Production Capacity

10, 000pieces/Year

Key features

Multi-Size Options: Available in 5mm, 10mm, 12mm, and 15mm diameters for various surgical needs.

CE & ISO Certified: Meets CE and ISO13485 standards for safety and quality assurance.

Disposable Design: Single-use plastic construction ensures hygiene and prevents cross-contamination.

Bladeless Safety: Bladeless design minimizes tissue damage during laparoscopic procedures.

Transparent Material: Transparent plastic body allows clear visibility during surgery.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export ExperienceExhibition Experience

Changzhou Medical Bioengineering Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/FactoryExport Year: 2010-10-01Nearest Port: Shanghai, NingboAverage Response Time: ≤0.01hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, FCA

AI-Powered supplier vetting

SummaryThe supplier is identified as a combined company with manufacturing, export, service, quality-control, and R&D-related capabilities. It reports clear procedures and records for corrective/preventive actions, customer complaints, and supplier-service assessment, as well as quality assurance in quality-control processes. Production information covers four disposable medical products with stated annual outputs, supported by injection molding, cleaning, and assembly facilities. The supplier offers sample-, design-, full-, and flexible-customization, 3D design, ODM, and OEM services. However, the evidence also shows no new products in the past year, no available R&D audit documentation, no valid manufacturing-capacity contract with related subcontractors, and no overseas agents, branches, warehouse, or showroom. Financial credibility cannot be assessed from the non-monetary information provided.

Supplier typeThe supplier is described as a combined company, and its stated business scope includes permitted medical mask production subject to applicable approvals and restrictions. The available information supports classification as a manufacturing-related medical-products supplier, but does not establish a more specific legal or ownership type.

After-Sales capabilityThe supplier reports documented procedures and followed records for corrective and preventive actions, customer complaints, and supplier-service assessment. It also states that engineers provide technical support for production and after-sales service, but it lacks overseas agents, branches, warehouses, and showrooms, limiting evidence of localized overseas support.

Production capacityThe supplier reports annual outputs of 300,000 disposable skin staplers, 200,000 disposable infusion pumps, 100,000 circumcision staplers, and 200,000 disposable laparoscopic trocars, supported by injection molding, cleaning, and assembly facilities. It also reports inventory capability and lead times within 15 workdays in both peak and off-seasons, although no valid manufacturing-capacity contract exists with related subcontractors.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, flexible customization, 3D software design, and ODM services. These statements provide direct evidence of broad product customization capability.

Client casesThe supplier reports participation in Medica 2023 and states that it provides OEM services for well-known brands. These are direct indications of market or customer experience, but no customer names, product examples, order details, or independently verifiable case documentation are provided.